Moderna stock price could surge another 45% on COVID-19 vaccine - Business Insider

📆 13-07-20 19:57:00
📰 BusinessInsider

⏱ Reading Time:
23 sec. here
2 min. at publisher
📊 Quality Score:
News: 13%
Publisher: 51%

Belgique Nouvelles Nouvelles

Belgique Dernières Nouvelles,Belgique Actualités

Moderna is poised to surge another 45% in the next year, COVID-19 vaccine could generate more than $5 billion in annual sales, Jefferies says

is set to surge higher even after its epic 220% rally so far this year, according to Jefferies.

The bullish rating hinges on Moderna's COVID-19 vaccine working and resulting in large government supply contracts, Jefferies equity analyst Michael Yee wrote in a Monday note. In the first full year of sales of its potential vaccine, Jefferies' model shows it could bring in $2 billion worldwide if roughly 50 million people get the vaccine at $50. This could grow to a peak of $5 billion between 2025 and 2026, according to the note.

Écrire un Commentaire

English press release of Dr. Zelenko new study. Please share. Treat early and live. Combo works.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

ICU head in Bergamo, Italy, says COVID-19 causing 'chronic damage' - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
La source: BusinessInsider - 🏆 729. / 51 Lire la suite »